Previous 10 | Next 10 |
home / stock / medif / medif news
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, March 01, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a gl...
Auxly has struggled recently due to many investment losses and large cash burn that led to significant dilutive financings. Despite reaching ~$50M in annualized sales during Q3, Auxly remains unprofitable, and it issued going concern warnings in Q3 before raising additional equity in ...
MediPharm shares fell more than 90% since reaching a peak in 2019 as a result of a total collapse in its revenue in just one year. The company lost the majority of its wholesale revenue as the market became oversupplied, and its white label business was inadequate. The company los...
MediPharm is focused on the global cannabis market, which will be much larger than North America. It is years ahead of most companies in regulatory, licensing, and certification requirements for global cannabis. MediPharm is an undiscovered gem. For further details see: ...
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – February 23, 2021 – The cannabis industry is once again gaining momentum as new jusidicitions open to CBD and North American cannabis companies find their footing. As the industry re...
Palm Beach, FL – February 18, 2021 – The personal care industry has witnessed a shift in consumer demand toward CBD infused skin & healthcare products over the past years and is expected to continue to grow for years to come. The sale of American-produced CBD personal care...
Mexico with 121 million citizens will likely legalize cannabis by April of this year opening the door to the largest population for potential customers; This will be a game-changing tipping point for legalization of cannabis around the world and especially throughout Latin America; ...
MediPharm Labs (MEDIF) announces that it has received a Cannabis Drug Licence ((CDL)) from Health Canada, which will enable the company to manufacture and supply drugs that contain cannabis.The company is positioned to supply cannabis based pharmaceutical drugs and active pharmaceutical ingre...
TORONTO, Feb. 17, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”), a global leader in specialized, research-driven cannabis extraction, distillation and derivative products, announced it has ...
After a two-year dark night, a new dawn is here for cannabis investors. Cannabis companies have stronger fundamentals that will drive the sector higher over the next five years. Investors can now have more clarity about which companies have the greatest potential for growth. ...
News, Short Squeeze, Breakout and More Instantly...
MediPharm Labs Announces Voting Results From the 2024 Annual Meeting of Shareholders Canada NewsWire TORONTO , June 26, 2024 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company"), a pharmaceutical comp...
MediPharm Labs Acquires Advanced Medical Cannabis Delivery Method Technology from Remidose Aerosols Canada NewsWire MediPharm has licenced global manufacturing, distribution, and sales rights of the novel advanced medical cannabis technology from Remidose Aerosols. Product...